Cases
Envision Healthcare Corporation (NYSE: EVHC)
Securities Class Action
Overview
Overview
- Date:
- 7/26/2017
- Company Name:
- Envision Healthcare Corporation
- Stock Symbol:
- EVHC
- Status:
- Closed/Complete
NEW YORK, July 26, 2017 – Bragar Eagel & Squire, P.C. is investigating potential claims against Envision Healthcare Corporation. (NYSE: EVHC). Our investigation concerns whether EVHC has violated the federal securities laws and/or engaged in other unlawful business practices.
On July 24, 2017, The New York Times reported that physicians associated with a subsidiary of Envision, EmCare Holdings, Inc., were disproportionately likely to engage in "surprise billing," which occurs when patients go to in-network hospitals, but are treated by out-of-network doctors and then billed at higher rates.
Following this news, shares of EVHC fell $3.73 over two trading days, or over 5.9%, to close at $58.88 on July 25, 2017.
If you purchased or otherwise acquired Envision Healthcare securities and suffered a loss, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Melissa Fortunato by email at investigations@bespc.com, or telephone at (212) 355-4648, or by filling out the contact form below. There is no cost or obligation to you.
On July 24, 2017, The New York Times reported that physicians associated with a subsidiary of Envision, EmCare Holdings, Inc., were disproportionately likely to engage in "surprise billing," which occurs when patients go to in-network hospitals, but are treated by out-of-network doctors and then billed at higher rates.
Following this news, shares of EVHC fell $3.73 over two trading days, or over 5.9%, to close at $58.88 on July 25, 2017.
If you purchased or otherwise acquired Envision Healthcare securities and suffered a loss, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Melissa Fortunato by email at investigations@bespc.com, or telephone at (212) 355-4648, or by filling out the contact form below. There is no cost or obligation to you.